As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
The Anatolian Journal of Cardiology
Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?” [Anatol J Cardiol]
Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”
Ferhat Dindaş1, Hüseyin Güngör2, Mehmet Ekici3, Pınar Akokay4, Füsun Erhan5, Mustafa Doğduş1, Mehmet Birhan Yılmaz61Department of Cardiology, Faculty of Medicine, Uşak Training and Research Hospital, Uşak, Turkey 2Department of Pharmacology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey 3Department of Physiology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey 4Department of Histology, İzmir Kavram Vocational School, İzmir, Turkey 5Department of Histology, Faculty of Veterinary, Cumhuriyet University, Sivas, Turkey 6Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
Ferhat Dindaş, Hüseyin Güngör, Mehmet Ekici, Pınar Akokay, Füsun Erhan, Mustafa Doğduş, Mehmet Birhan Yılmaz. Reply to Letter to the Editor: “Can ARNI Prevent Doxorubicin-Induced Cardiotoxicity?”. Anatol J Cardiol. 2022; 26(4): 344-344
Corresponding Author: Ferhat Dindaş, Türkiye Manuscript Language: English